Lexeo Therapeutics
Lexeo Therapeutics Slashes IPO Price to Secure $100M Funding
Anika Sharma
Lexeo Therapeutics has revealed its intention to generate substantial capital through a Nasdaq listing, despite having recently scaled back its ...
Biotech IPOs: Abivax and Lexeo debut on Nasdaq, Apnimed delays listing
Anika Sharma
AbiVax and Lexeo Therapeutics have recently made their debut in the world of initial public offerings (IPOs), marking the commencement ...
